BDH-Clinic Hessisch Oldendorf, Institute for Neurorehabilitation Research, Associated Institute of Hannover Medical School, Hessisch Oldendorf, Germany.
Department of Rehabilitation Medicine, Hannover Medical School, Hannover, Germany.
BMC Neurol. 2022 Sep 6;22(1):333. doi: 10.1186/s12883-022-02855-3.
A reliable assessment of the functional abilities of patients after severe brain damage is crucial for valid prognostication and treatment decisions, but most clinical scales are of limited use among this specific group of patients.
The present study investigates the usefulness of the Early Functional Ability (EFA) scale, which determines the functional abilities of severely impaired patients.
Critically ill patients consecutively admitted to early neurological rehabilitation were screened for eligibility. We assessed the correlation between the EFA scale and (i) the Early Rehabilitation Barthel Index (ERBI), and (ii) the Coma Recovery Scale-Revised (CRS-R). The 1-year outcome on the Glasgow Outcome Scale-extended (GOSE) was used to examine the predictive validity. Demographical and medical variables were entered into univariate and multivariate binary regression models to identify independent predictors of 1-year outcome.
Two hundred fifty-seven patients (168 men) with a median age of 62 years (IQR = 51-75) were enrolled. The correlation of the EFA scale with the CRS-R was high but low with the ERBI upon admission. Multivariate regression analysis yielded the vegetative subscale of the EFA scale as the only independent predictor for the 1-year outcome of patients admitted to early neurological rehabilitation.
This study shows a high correlation of the EFA scale with the CRS-R but a weak correlation with the ERBI in patients with low functional abilities. With improving patient abilities, these correlations were partly reversed. Thus, the EFA scale is a useful tool to assess the functional abilities and the prognosis of critically ill patients adequately and may be more feasible than other scales.
对于严重脑损伤后的患者,可靠地评估其功能能力对于有效的预后和治疗决策至关重要,但大多数临床量表在这群特定患者中的应用有限。
本研究调查了早期功能能力(EFA)量表的实用性,该量表用于确定严重受损患者的功能能力。
连续筛选入住早期神经康复的危重症患者,以确定其是否符合入选标准。我们评估了 EFA 量表与(i)早期康复巴氏量表(ERBI)和(ii)昏迷恢复量表修订版(CRS-R)之间的相关性。使用格拉斯哥预后扩展量表(GOSE)的 1 年结局来检验预测效度。将人口统计学和医学变量纳入单变量和多变量二分类回归模型,以确定 1 年结局的独立预测因素。
共纳入 257 名患者(168 名男性),中位年龄为 62 岁(IQR=51-75)。EFA 量表与 CRS-R 的相关性较高,但与入院时的 ERBI 相关性较低。多变量回归分析显示,EFA 量表的植物状态亚量表是预测早期神经康复患者 1 年结局的唯一独立预测因素。
本研究表明,EFA 量表与 CRS-R 相关性较高,与 ERBI 相关性较低,适用于功能能力较低的患者。随着患者能力的提高,这些相关性部分逆转。因此,EFA 量表是一种评估危重症患者功能能力和预后的有用工具,可能比其他量表更可行。